BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16601488)

  • 1. Strategies to prevent neuronal damage in paediatric bacterial meningitis.
    Grandgirard D; Leib SL
    Curr Opin Pediatr; 2006 Apr; 18(2):112-8. PubMed ID: 16601488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current views on the pathophysiology of bacterial meningitis--new therapeutic possibilities?].
    Kepa L
    Pol Merkur Lekarski; 1997 Dec; 3(18):291-4. PubMed ID: 9523471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Supportive (antiinflammatory) treatment of bacterial meningoencephalitis with dexamethasone].
    Szychowska Z
    Pol Merkur Lekarski; 1997 Apr; 2(10):291-4. PubMed ID: 9377671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury.
    Scheld WM; Koedel U; Nathan B; Pfister HW
    J Infect Dis; 2002 Dec; 186 Suppl 2():S225-33. PubMed ID: 12424702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiinflammatory but no neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacterial meningitis.
    Spreer A; Gerber J; Baake D; Hanssen M; Huether G; Nau R
    J Neurosci Res; 2006 Nov; 84(7):1575-9. PubMed ID: 16998917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In search of strategies for preventing brain damage as a sequela of bacterial meningitis].
    Leib SL; Täuber MG
    Schweiz Med Wochenschr; 2000 Jun; 130(24):928-35. PubMed ID: 10909719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor rescues neurons from bacterial meningitis.
    Li L; Shui QX; Liang K; Ren H
    Pediatr Neurol; 2007 May; 36(5):324-9. PubMed ID: 17509465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial.
    Peltola H; Roine I; Fernández J; Zavala I; Ayala SG; Mata AG; Arbo A; Bologna R; Miño G; Goyo J; López E; de Andrade SD; Sarna S
    Clin Infect Dis; 2007 Nov; 45(10):1277-86. PubMed ID: 17968821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment.
    Klein M; Koedel U; Kastenbauer S; Pfister HW
    Infection; 2008 Feb; 36(1):2-14. PubMed ID: 18084715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal bacterial meningitis and dexamethasone adjunctive usage in Nigeria.
    Airede KI; Adeyemi O; Ibrahim T
    Niger J Clin Pract; 2008 Sep; 11(3):235-45. PubMed ID: 19140361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids for acute adult bacterial meningitis.
    van de Beek D
    Med Mal Infect; 2009; 39(7-8):531-8. PubMed ID: 19386456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology of neuronal injury in bacterial meningitis and experimental adjunctive therapeutic approaches].
    Böttcher T
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S7-9. PubMed ID: 19685399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of dexamethasone in the treatment of purulent meningitis in infants and in children].
    Grimprel E; Bégué P
    Pediatrie; 1993; 48(1):29-36. PubMed ID: 8392688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to reduce neuronal cell death in bacterial meningitis.
    Eisenhut M
    Crit Care Med; 2008 May; 36(5):1678-9. PubMed ID: 18448941
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
    Liu X; Han Q; Sun R; Li Z
    Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone and long-term outcome in adults with bacterial meningitis.
    Weisfelt M; Hoogman M; van de Beek D; de Gans J; Dreschler WA; Schmand BA
    Ann Neurol; 2006 Oct; 60(4):456-68. PubMed ID: 16958121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial meningitis: current therapy and possible future treatment options.
    Woehrl B; Klein M; Grandgirard D; Koedel U; Leib S
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1053-65. PubMed ID: 22029523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for acute bacterial meningitis.
    Deghmane AE; Alonso JM; Taha MK
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):381-93. PubMed ID: 19624284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Insight: adjunctive therapies in adults with bacterial meningitis.
    van de Beek D; Weisfelt M; de Gans J; Tunkel AR; Wijdicks EF
    Nat Clin Pract Neurol; 2006 Sep; 2(9):504-16. PubMed ID: 16932615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
    Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
    Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.